ArticleThe Journal of rheumatology2023

Relapse Risk and Safety of Long-Term Tocilizumab Use Among Patients With Giant Cell Arteritis: A Single-Enterprise Cohort Study.

Matthew J Samec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.